Status:
COMPLETED
Nudges and Incentives to Enhance the Opioid Treatment Workforce
Lead Sponsor:
University of North Carolina, Chapel Hill
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Opioid Abuse (Disorder)
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
This project seeks to examine a critical barrier to optimizing the health care workforce for the treatment of opioid use disorders. Without a dramatic increase in the number of primary care providers ...
Detailed Description
This study is designed to assess how to effectively recruit and enroll primary care providers into participation into an ECHO MAT learning collaborative. For study participants that enroll in the lear...
Eligibility Criteria
Inclusion
- Licensed Primary Care Provider (Doctor of Medicine (MD), Doctor of Osteopathic Medicine (DO), Physician Assistant (PA), Nurse Practitioner (NP))
- Currently practice in North Carolina
- For Nurse practitioners, the following specialties were included:
- Addiction Psychiatry
- Addiction/Chemical Dependency
- Adolescent Medicine
- Emergency Medicine
- Family Practice
- Family Practice, Geriatric
- General Practice
- General Preventive Medicine
- Geriatrics
- Gerontology
- Gynecology
- Infectious Disease
- Internal Medicine
- Internal Medicine/Immunology Diagnostic
- Internal Medicine/Pulmonary Dis. \& Crit
- Medicine/Pediatrics
- Medicine/Psychiatry
- Obstetrics
- Obstetrics and Gynecology/Critical Care
- Obstetrics/Gynecology
- Other Specialty
- Pain Management (phys med)
- Pain Medicine
- Pediatrics
- Psychiatry
- Psychiatry, Child
- Psychiatry/Geriatric
- Public Health
- Unspecified
- Hospitalist
- For MD/DOs practitioners that were considered primary by the medical board care were included except those specializing in sports, addiction, alcohol, and surgery
- For PAs practitioners were included that are considered primary care by the medical board
Exclusion
- Another member of the same practice is already enrolled in the study (one provider per practice in Phase 2)
- Active participation in University of North Carolina at Chapel Hill (UNC) ECHO Collaborative at beginning of study
Key Trial Info
Start Date :
February 12 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 28 2020
Estimated Enrollment :
73 Patients enrolled
Trial Details
Trial ID
NCT03834025
Start Date
February 12 2019
End Date
August 28 2020
Last Update
August 20 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of North Carolina At Chapel Hill
Chapel Hill, North Carolina, United States, 27599-7411